Home / Clinical Decision Support & Reference / Cartesion Prime (PCD-1000A/3) V10.21

Cartesion Prime (PCD-1000A/3) V10.21

by Canon Medical Systems USA, Inc. · Based in United States → — A well-balanced, premium digital PET-CT that delivers exceptional image quality with accurate quantification, reduced scan times and improved signal to noise and dose efficiencies.

Nuclear Medicine Oncology Radiology

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Overview

The Cartesion Prime (PCD-1000A/3) V10.21 is a premium digital PET/CT scanner designed to provide high-quality images for various clinical applications. It combines a high-end CT system (Aquilion Prime SP CT) with a high-throughput digital PET detector utilizing Silicon Photo-Multiplier (SiPM) sensors. The system features a 27cm axial field-of-view, 100% SiPM coverage with one-to-one crystal coupling, and fast time-of-flight (TOF) resolution (typically 238 ps). A key innovation is its air-cooling technology, which can reduce installation complexity, maintenance costs, and siting requirements compared to traditional water-cooled systems. The Cartesion Prime also incorporates Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) deep learning reconstruction technology for both PET and CT, which aims to improve image quality, reduce noise, and potentially shorten scan times while maintaining or improving diagnostic confidence. The system is designed with a patient and operator-centric approach, featuring a wide 78 cm gantry bore and a wide patient couch for enhanced comfort and easier patient access.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Use Cases

Diagnosis and staging of cancer
Assessment of treatment response in oncology
Evaluation of metabolic and physiologic functions
Cardiac imaging
Neurological imaging
Radiation therapy planning

What Physicians Need to Know

Evidence Base

The Cartesion Prime (PCD-1000A/3) V10.21 is a diagnostic imaging system combining Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) systems. It utilizes advanced technologies like deep learning artificial neural networks (AiCE-i for PET) to improve image quality and reduce noise in PET data. The system's design incorporates Silicon Photo-Multiplier (SiPM) technology for enhanced sensitivity, timing resolution, and overall image quality. The device is intended to gather metabolic and functional information from radiopharmaceutical distribution to assist in the evaluation, detection, localization, diagnosis, staging, restaging, follow-up, and therapeutic assessment of oncological, cardiovascular, and neurological diseases and disorders. It also includes a Deviceless PET Respiratory gating system to automatically generate a gating signal from list-mode PET data for motion-corrected images, particularly for lesions in the thorax, abdomen, and pelvis affected by respiratory motion.

Clinical Validation Studies

Clinical evaluations for the Cartesion Prime (PCD-1000A/3) V10.21 involved three physicians with at least 20 years of experience in nuclear medicine. They evaluated respiratory-gated images of ten patients using Deviceless PET Respiratory gating, non-gated images, and device-based gating. All physicians determined that the images were of diagnostic quality, and deviceless gated images showed similar or better performance than device-based gated images, with improved motion correction compared to non-gated images. Additionally, the performance of AiCE-i for PET was evaluated using ten PET DICOM clinical 18F-FDG whole-body cases, comparing Sharp, Smooth, and Standard intensity settings to OSEM and Gaussian filter methods. All three physicians reported that AiCE-i images at all settings were of diagnostic quality, consistent across cases, and performed better in overall image quality and sharpness.

Alert Fatigue Management

While the system provides advanced imaging and reconstruction, specific details on 'alert fatigue management' in the context of clinical decision support for physicians were not explicitly found in the provided information. The focus is on image quality and diagnostic accuracy rather than alert generation for diagnosis and treatment decisions.

Differential Diagnosis Support

The Cartesion Prime (PCD-1000A/3) V10.21 is a diagnostic imaging system that aids clinicians in the detection, localization, evaluation, diagnosis, staging, restaging, and follow-up of various diseases and disorders, including oncological, cardiovascular, and neurological conditions. The system's ability to provide high-quality PET and CT images, enhanced by AI-assisted reconstruction (AiCE-i) and motion correction (Deviceless PET Respiratory gating), supports physicians in making informed diagnostic decisions.

Guideline Update Frequency

The provided information does not specify a 'guideline update frequency' for the Cartesion Prime (PCD-1000A/3) V10.21. The device itself is a diagnostic imaging system, and its software updates would likely be part of its maintenance and regulatory compliance, rather than frequent guideline updates in the traditional sense of clinical decision support. The device received premarket clearance from the FDA on December 1, 2025.

Clinical Workflow Integration

The Cartesion Prime (PCD-1000A/3) V10.21 is designed for streamlined workflow and improved throughput. It combines a high-end CT and a high-throughput PET system to acquire CT, PET, and fusion images. Features like a large axial field of view contribute to faster scans and improved sensitivity, which can impact dose efficiencies. The system also incorporates an operator-centric design with features aimed at reducing operator exposure dose. Its compact room design and air-cooling technology allow for installation in smaller spaces, further enhancing workflow and operational efficiency.

Decision Audit Trail

The provided information does not explicitly detail a 'decision audit trail' feature for the Cartesion Prime (PCD-1000A/3) V10.21. As a diagnostic imaging system, its primary function is image acquisition and processing, rather than generating and tracking physician decisions.

Physician Tip

Leverage the AiCE-i for PET's deep learning reconstruction with its three smoothing levels to optimize image quality and noise reduction according to specific clinical needs and preferences. Utilize the Deviceless PET Respiratory gating system, especially for studies involving the thorax, abdomen, and pelvis, to achieve motion-corrected images and improve diagnostic accuracy. The system's high-quality PET and CT fusion images are valuable for comprehensive evaluation, detection, and staging of oncological, cardiovascular, and neurological diseases. The operator-centric design and workflow enhancements can contribute to more efficient examinations and potentially reduced operator exposure.

The Cartesion Prime (PCD-1000A/3) V10.21 integrates a high-end CT system (Aquilion Prime SP CT) with a high-throughput digital PET detector. It utilizes SiPM photosensors and AI-assisted reconstruction (AiCE for PET and CT) for enhanced image quality and denoising. The system is designed to acquire and fuse CT and PET images, with CT images used for attenuation correction and anatomical reference. While not explicitly detailed, its role as a diagnostic imaging system suggests compatibility with standard medical imaging archives and viewing platforms (e.g., PACS) for image storage and review.

At a glance

Deployment On Premise

Details

Category	Clinical Decision Support & Reference, Oncology AI, Radiology & Imaging AI
Pricing	Unknown — unknown
Deployment	On-premise
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	Unknown AI-estimated The Cartesion Prime (PCD-1000A/3) V10.21 has received FDA 510(k) premarket clearance. Its Advanced intelligent Clear-IQ Engine (AiCE) deep learning reconstruction technology for PET/CT also received FDA clearance.
Integrations
EHR	Not specified
Specialties	Nuclear Medicine, Oncology, Radiology

What the Web Says

The Canon Medical Cartesion Prime (PCD-1000A/3) V10.21 is a premium digital PET/CT scanner that has garnered positive attention from physicians and healthcare providers. It is praised for its advanced SiPM PET detector and Aquilion Prime SP CT system, which work together to deliver high-quality images, reduce scan times, and optimize dose efficiency. The system also incorporates AI-assisted reconstruction technology (AiCE and AiCE-i) for enhanced image clarity and noise reduction.

Overall: Positive

Strengths

Excellent image quality and accurate quantification, even with reduced doses.
Fast scan times and increased patient throughput due to a large axial field of view and optimized workflow.
Air-cooling technology, which simplifies siting, reduces installation and maintenance costs, and allows for a smaller footprint.
Patient-centric design with a wide bore, flared gantry, and low couch height for improved patient comfort and reduced anxiety.
AI-assisted reconstruction (AiCE and AiCE-i) significantly improves image quality, reduces noise, and enhances the detection of subtle lesions.
Reliable system performance and ease of use for staff.

Limitations

High initial cost.
No specific negative reviews or opinions were found from the searched sources (Reddit, G2, Capterra, or tech reviewers outside of medical imaging publications).

Based on reviews from: Canon Medical Systems, Vertex AI Search, G-MedTech, FDA, Hardian Health

Last updated: 2026-07-28

Ratings & Reviews

Rate Cartesion Prime (PCD-1000A/3) V10.21

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

FDA

510(k) Premarket Notification K251370 - Cartesion Prime (PCD-1000A/3) V10.21

This regulatory announcement details the FDA's premarket clearance for the Cartesion Prime (PCD-1000A/3) V10.21, stating its substantial equivalence to a previous version and outlining its features as a high-end CT and high-throughput PET system.

2025-12

RadPigeon

Cartesion Prime (PCD-1000A/3) V10.21 u00b7 RadPigeon

RadPigeon, an AI Devices registry, lists the Cartesion Prime (PCD-1000A/3) V10.21 by Canon Medical Systems Corporation.

2026-07

Radiology AI Tools Directory

Search FDA-cleared listings - Radiology AI Tools Directory

This directory includes the Cartesion Prime (PCD-1000A/3) V10.21 among FDA-cleared radiology AI listings, noting its modality as PET/SPECT/Nuclear Medicine and the decision date.

2025-12

FDA

Establishment Registration & Device Listing - accessdata.fda.gov

The FDA's Establishment Registration & Device Listing includes the Cartesion Prime (PCD-1000A/3) V10.21, indicating its regulatory status.

2026-04

FDA

TPLC - Total Product Life Cycle - FDA

The FDA's Total Product Life Cycle database lists the Cartesion Prime (PCD-1000A/3) V10.21 with its 510(k) number K251370, indicating its regulatory journey.

2026-07

FDA 510(k) Database

Cartesion Prime (PCD-1000A/3) V10.21 (K251370) u2014 FDA 510(k)

This FDA 510(k) entry provides details on the Cartesion Prime (PCD-1000A/3) V10.21, including the applicant Canon Medical Systems Corporation and the correspondent.

2025-12

Radiology AI Tools Directory

PET/SPECT/Nuclear Medicine radiology AI tools | FDA-cleared directory

The Cartesion Prime (PCD-1000A/3) V10.21 is listed in an FDA-cleared directory for PET/SPECT/Nuclear Medicine radiology AI tools, with Canon Medical Systems Corporation as the manufacturer.

2025-12

FDA.report

CANON INC. FDA Filings - FDA.report

This report on Canon Inc.'s FDA filings includes the Cartesion Prime (PCD-1000A/3) V10.21, noting its product code and the date of its FDA clearance.

2025-12

Videos

Product demos, reviews, and walkthroughs for Cartesion Prime (PCD-1000A/3) V10.21.

Loading videos...

View all on YouTube

Frequently Asked Questions

What is Cartesion Prime (PCD-1000A/3) V10.21 and what are its primary clinical applications?

Cartesion Prime (PCD-1000A/3) V10.21 is a diagnostic imaging system that integrates high-end CT and high-throughput PET technologies. It's designed to acquire CT, PET, and fusion images to gather metabolic and functional information from radiopharmaceutical distribution in the body. This information assists in the evaluation, detection, localization, diagnosis, staging, restaging, follow-up, and therapeutic planning/outcome assessment of various oncological, cardiovascular, and neurological diseases and disorders.

How does Cartesion Prime V10.21 enhance clinical decision support, particularly with its new features?

The V10.21 version includes features like AiCE-i for PET and a Deviceless PET Respiratory Gating system. AiCE-i for PET utilizes deep learning to improve image quality and reduce noise in FDG whole-body data, aiding in clearer visualization and more confident clinical results. The Deviceless PET Respiratory Gating system automatically generates a gating signal from list-mode PET data to reconstruct motion-corrected images, which is crucial for accurate assessment of lesions affected by respiratory motion in areas like the thorax, abdomen, and pelvis.

What are the regulatory compliance aspects for Cartesion Prime (PCD-1000A/3) V10.21?

As a Class II medical device, Cartesion Prime (PCD-1000A/3) V10.21 must comply with all FDA requirements, including registration and listing (21 CFR Part 807), labeling (21 CFR Part 801), and medical device reporting (21 CFR Part 803). It also needs to adhere to good manufacturing practice requirements (21 CFR Part 820) and the Unique Device Identification (UDI) System rule.

Are there alternative PET/CT systems to Cartesion Prime (PCD-1000A/3) V10.21 that offer similar clinical decision support capabilities?

While the specific alternatives with identical feature sets to Cartesion Prime V10.21 are not detailed, other manufacturers offer digital PET/CT systems. These systems often aim for high image quality, accurate quantification, and dose optimization, and may incorporate AI-assisted reconstruction and motion management. Physicians would need to compare specifications, features, and clinical evidence from various vendors to determine the best fit for their practice.

What are the potential limitations of Cartesion Prime (PCD-1000A/3) V10.21 that a physician should consider?

While Cartesion Prime V10.21 offers advanced features, potential limitations could include the need for trained healthcare professionals for operation and interpretation of results. The effectiveness of AI-assisted technologies can also vary depending on the clinical setting and patient presentation. Specific limitations regarding scan times, patient throughput, or the scope of its AI algorithms for less common conditions would require further investigation.

How does Cartesion Prime (PCD-1000A/3) V10.21 address patient comfort and dose optimization?

The system is designed with a patient-centric approach, featuring a wide 78 cm bore with a flared gantry and a wide patient couch for a more open and comfortable environment. Its low minimum bed height facilitates easier and safer patient access. The digital PET detector and AI-assisted technologies aim to optimize dose while maintaining high image quality and accurate quantification, potentially leading to dose efficiencies.

What are the cost implications or pricing models for acquiring and maintaining Cartesion Prime (PCD-1000A/3) V10.21?

Specific pricing for Cartesion Prime (PCD-1000A/3) V10.21 is not publicly available in the provided information. However, Canon Medical Systems emphasizes that the Cartesion Prime is designed to reduce the total cost of ownership, partly through its air-cooling technology, which can support more attractive siting and long-term maintenance requirements compared to water-cooled systems. Individual costs for purchase, siting, and maintenance will vary by vendor, institution, and contractual agreements.